InsiderPulse
CGNX

CGNXCOGNEX CORP

Health CareIndustrial Instruments For Measurement, Display, and Control
SEC ↗
MetricFY2025FY2025FY2025FY2025FY2024FY2024FY2024FY2024FY2023FY2023
Revenue$994.4M+8.7%$914.5M+9.2%$837.5M
Cost of revenue$329.0M+13.9%$288.7M+22.2%$236.3M
Gross margin$665.4M+6.3%$625.8M+4.1%$601.2M
Research, development, and engineering expenses$139.0M-0.6%$139.8M+0.3%$139.4M
Selling, general, and administrative expenses$363.9M-1.9%$370.9M+9.4%$339.1M
Loss (recovery) from fire$0$0+100.0%-$8.0M
Operating income$162.6M+41.3%$115.1M-12.0%$130.7M
Foreign currency gain (loss)-$4.1M-366.6%$1.5M+115.3%-$10.0M
Investment income$16.9M+21.3%$14.0M-0.9%$14.1M
Other income (expense)$7.4M+699.1%$922K+55.7%$592K
Income before income tax expense$182.8M+39.0%$131.5M-2.9%$135.3M
Income tax expense on continuing operations$68.4M+170.0%$25.3M+14.5%$22.1M
Net income$114.4M+7.8%$106.2M-6.2%$113.2M
Net income (in dollars per share)$680+9.7%$620-4.6%$650
Basic (in shares)$168.0M-2.0%$171.4M-0.5%$172.2M
Diluted (in shares)$169.4M-1.9%$172.6M-0.5%$173.4M
Cash dividends per common share (in dollars per share)$85+6.3%$80+0.0%$80+0.0%$80-73.8%$305+306.7%$75+0.0%$75+0.0%$75-73.8%$286+308.6%$70

Source: SEC EDGAR XBRL. % change vs prior period shown where available.

Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.